Modern HRT does not raise heart disease risk in women — large AHA study
Published: · Русский · O‘zbekcha
A 12-year study of 52,330 women aged 45–59 (AHA Scientific Sessions 2026, November 2): modern hormone replacement therapy was not associated with higher rates of heart attack, stroke or early death.

The Israeli observational study used matched Clalit Health Services records. None of the women had prior cardiovascular disease. Average follow-up was 12 years, up to 23 years.
Key results: heart attack, stroke or related disease 4.4% (HRT) vs 4.6% (no HRT); death before age 80 at 1.3% vs 1.2%; blood clots at approximately 0.33% in both groups. Results were consistent across oral, patch and gel formulations.
This is a preliminary, observational study — it does not prove causation and has not yet been peer-reviewed. In November 2025, the FDA removed the black-box warning from HRT products. All decisions about hormone therapy should be made in consultation with a physician.
Source: American Heart Association · Read the original source ↗
Share this news




